search
Back to results

Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.

Primary Purpose

Anxiety Depression, CBT

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Unified Protocol (UP-C/A) for children and youth with anxiety disorders and /or depression
Sponsored by
Lena Reuterskiold
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety Depression focused on measuring Unified Protocol

Eligibility Criteria

7 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 7-17 years of age Anxiety syndrome, obsessive-compulsive disorder and/or depression according to the Diagnostic and Statistical Manual of Mental disorders (DSM) as primary problem Patients and parents master the Swedish language without interpreter support. Willingness/ability to participate after receiving information about what participation entails In case of medication, this is on a stable dose, since six weeks Exclusion Criteria: Psychosis, bipolar disorder. substance use syndrome, severely suicidal or pervasive developmental disorder Ongoing other psychological treatment Abuse or domestic violence

Sites / Locations

  • Liljeholmens VårdcentralRecruiting
  • Älvsjö VårdcentalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Unified Protocol (UP-C/A) for children and youth with anxiety disorders and/or depression

Arm Description

A within group design where one clinical manualised intervention, the Unified protocol based on the third-wave of Cognitive Behavior Therapy (CBT), is offered in a 11 session group format to children and adolescents. Parent training is at the same time also offered in a group format. Therapists are trained in the method and receive regular supervision adhering to the evidence-based manual. The group treatment and parent training is delivered face-to- face.

Outcomes

Primary Outcome Measures

Emotion Regulation Index for Children and Adolescents (ERICA)
A self-report that measures various aspects of emotion regulation with three subscales: 1: Emotional Control (lower scores indicate more emotional control); 2: Emotional Self-Awareness (higher scores indicate more emotional self-awareness); 3: Situational Responsiveness (higher scores indicate more situational responsiveness). 16 items in total. Some scores are reversed. Likert-type scale 1 to 5.

Secondary Outcome Measures

Revised Children's Anxiety and Depression Scale (R-CADS)
A self-report and parent report that measures symptoms of anxiety and depression. Minimum value 0 and maximum 141, where higher scores indicate more anxiety and depression symptoms.
The Strengths and difficulties questionnaire (SDQ)
A self-report for children from 11 years of age and their parents that assessing mental health, behavior and peer problems in children 7-17 years. Minimum value 0, maximum 40. Higher scores indicate more problems, apart from the prosocial subscale where higher scores indicate more prosocial behavior.
Kidscreen-10 Index
A brief self-report, with 10 items, for children and their parents intended to measure health-related quality of life. Scores range from 1 to 5. Higher scores generally indicate a better quality of life, some scores have to be reversed.
Children's Global Assessment Scale (C-GAS).
Assessment of the child´s functional level by the clinician. Scores range from 0-100, with higher scores indicating a higher functioning.
Client Satisfaction Questionnaire (CSQ-8)
A child and parent self-report on general treatment satisfaction. Scores range from 8-32, with higher scores indicating more satisfaction.
A scale on the Acceptability of Intervention Measure (AIM); Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM).
Clinician report. Three subscales, with scores ranging from a minimum of 12 and a maximum of 60. Higher scores indicating a better fit with implementation in clinic.

Full Information

First Posted
March 27, 2023
Last Updated
May 3, 2023
Sponsor
Lena Reuterskiold
search

1. Study Identification

Unique Protocol Identification Number
NCT05827809
Brief Title
Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.
Official Title
A Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth: Feasibility, Acceptability and Effect in a Clinical Open Trial in Primary Care
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 8, 2022 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Lena Reuterskiold

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this open clinical trial is to try out and evaluate a relatively new transdiagnostic psychological treatment, Unified Protocol (UP-C/A), in group format for children and adolescents aged 7-17 years of age with anxiety and/or depression and their parents, in primary care. The therapists in the project will receive training and on-going supervision in UP-C/A. The main questions it aims to answer are: What are the children's (patients) and parents experience of undergoing a transdiagnostic psychological treatment (UP-C/A) in primary care? What are the therapists' experience of having carried out the treatment with a transdiagnostic psychological treatment (UP-C/A) in primary care? To what extent do children and parents answer self-reports and clinician administered instruments regarding symptoms of anxiety, depression, function and quality of life? To what extent do children and their parents complete the treatment and what is the dropout rate? What does the distribution of diagnoses and co-morbidity look like for patients included in the study? What is the treatment outcome with regard to emotion regulation, symptoms of anxiety, depression, function and quality of life? rated by patients, parents and therapists. To what extent are any effects maintained at a 6-month follow-up? The participants and their parents will partake in group treatment with Unified Protocol of 11 sessions following an initial screening with the Mini International Neuropsychiatric Interview for children and adolescents (MINI-KID).
Detailed Description
Participants in the study are children (7 to 17 years of age) seeking help for anxiety and depression in routine primary care and their parents. The children are screened with the Mini-International Neuropsychiatric Interview for children and adolescents (MINI-KID). Patients assessed as fulfilling criteria for anxiety disorders, obsessive compulsive disorders and/or depression and checked against inclusion and exclusion criteria are informed about the project orally and in writing. Informed consent is obtained verbally and in writing. Recruitment in the two separate clinical sites continues until up to 8 children and their parents constitute a group. After inclusion children and their parents fill in self-report scales. Some of these self-report scales are already in use in the primary care platform (SDQ) and (R-CADS). The ERICA, KIDSCREEN-10, Client Safisfaction Questionnaire (CSQ) are in paperformat and saved in the clinic. The therapist in the project are asked to fill in a scale that assesses feasibility and acceptability of the intervention, after treatment completion. Data will be analysed descriptively to answer research question from self-reports from the children, parents and therapist as to satisfaction with treatment, feasibility and acceptability. Treatment effect will be analyzed with paired sample t-test on primary and secondary outcomes. Therapist have received training in UP-C/A by certified educators in UP and will receive on-going supervision in Unified-Protocol by a UP-certified psychologist, during the group intervention. Also, the group intervention is audio-taped. A random sample of 20% of the sessions will be rated as to compliance with the Unified Protocol. The ratings will be performed by the project investigator, also trained in UP-C/A. A sample size of about 30 is aimed for based on an average of 6 patients in a group and five treatment groups in total. One clinic is aiming for three groups and the other for two treatment groups. Detailed and clear information about the treatment, time consumption for child and parent groups and a good structure for data collection in the clinics are some planned strategies to minimize dropouts and data loss. From the overall collected data on child and parent satisfaction, therapist ratings of acceptability, feasibility and treatment effects at a 6-month follow-up, a randomized controlled trial (RCT) is planned for in primary care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Depression, CBT
Keywords
Unified Protocol

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
A clinical open trial evaluating feasibility, acceptability, treatment facilitators as well as treatment effects measured before, after and at 6-month follow-up, for a relatively new transdiagnostic psychological treatment, Unified Protocol, for children and youth with anxiety disorders and/or depression and their parents. The therapists in the project will also be in-depth interviewed about the treatment feasibility, compliance and acceptance of the treatment intervention. The study is conducted at 2 primary care clinics with patients and parents seeking for routine care.
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Unified Protocol (UP-C/A) for children and youth with anxiety disorders and/or depression
Arm Type
Experimental
Arm Description
A within group design where one clinical manualised intervention, the Unified protocol based on the third-wave of Cognitive Behavior Therapy (CBT), is offered in a 11 session group format to children and adolescents. Parent training is at the same time also offered in a group format. Therapists are trained in the method and receive regular supervision adhering to the evidence-based manual. The group treatment and parent training is delivered face-to- face.
Intervention Type
Behavioral
Intervention Name(s)
Unified Protocol (UP-C/A) for children and youth with anxiety disorders and /or depression
Intervention Description
A transdiagnostic psychological group treatment, Unified Protocol (UP-C/A), one intervention, is tested for children and youth with anxiety disorders and/or depression seeking help in routine care in two primary care locations. Parents are at the same time offered parent training in a group format coupled with the module the children are working on. Feasibility, acceptability and effect of the intervention will be studied, with child self-report, parent-report and therapist assessment.
Primary Outcome Measure Information:
Title
Emotion Regulation Index for Children and Adolescents (ERICA)
Description
A self-report that measures various aspects of emotion regulation with three subscales: 1: Emotional Control (lower scores indicate more emotional control); 2: Emotional Self-Awareness (higher scores indicate more emotional self-awareness); 3: Situational Responsiveness (higher scores indicate more situational responsiveness). 16 items in total. Some scores are reversed. Likert-type scale 1 to 5.
Time Frame
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Secondary Outcome Measure Information:
Title
Revised Children's Anxiety and Depression Scale (R-CADS)
Description
A self-report and parent report that measures symptoms of anxiety and depression. Minimum value 0 and maximum 141, where higher scores indicate more anxiety and depression symptoms.
Time Frame
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Title
The Strengths and difficulties questionnaire (SDQ)
Description
A self-report for children from 11 years of age and their parents that assessing mental health, behavior and peer problems in children 7-17 years. Minimum value 0, maximum 40. Higher scores indicate more problems, apart from the prosocial subscale where higher scores indicate more prosocial behavior.
Time Frame
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Title
Kidscreen-10 Index
Description
A brief self-report, with 10 items, for children and their parents intended to measure health-related quality of life. Scores range from 1 to 5. Higher scores generally indicate a better quality of life, some scores have to be reversed.
Time Frame
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Title
Children's Global Assessment Scale (C-GAS).
Description
Assessment of the child´s functional level by the clinician. Scores range from 0-100, with higher scores indicating a higher functioning.
Time Frame
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Title
Client Satisfaction Questionnaire (CSQ-8)
Description
A child and parent self-report on general treatment satisfaction. Scores range from 8-32, with higher scores indicating more satisfaction.
Time Frame
After treatment completion at 12 weeks.
Title
A scale on the Acceptability of Intervention Measure (AIM); Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM).
Description
Clinician report. Three subscales, with scores ranging from a minimum of 12 and a maximum of 60. Higher scores indicating a better fit with implementation in clinic.
Time Frame
After the treatment group intervention is completed at 12 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 7-17 years of age Anxiety syndrome, obsessive-compulsive disorder and/or depression according to the Diagnostic and Statistical Manual of Mental disorders (DSM) as primary problem Patients and parents master the Swedish language without interpreter support. Willingness/ability to participate after receiving information about what participation entails In case of medication, this is on a stable dose, since six weeks Exclusion Criteria: Psychosis, bipolar disorder. substance use syndrome, severely suicidal or pervasive developmental disorder Ongoing other psychological treatment Abuse or domestic violence
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lena Reuterskiöld, PhD
Phone
+46702580625
Email
lena.reuterskiold@regionstockholm.se
First Name & Middle Initial & Last Name or Official Title & Degree
Tobias Lundgren, PhD
Phone
+46706124555
Email
tobias.lundgren@regionstockholm.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lena Reuterskiöld, PhD
Organizational Affiliation
Region Stockholm
Official's Role
Principal Investigator
Facility Information:
Facility Name
Liljeholmens Vårdcentral
City
Stockholm
ZIP/Postal Code
11794
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lena Reuterskiöld, PhD
Phone
+46702580625
Email
lena.reuterskiold@regionstockholm.se
First Name & Middle Initial & Last Name & Degree
Director
Phone
+46812367751
Email
sandra.afwinklerfelt-hammarberg@regionstockholm.se
Facility Name
Älvsjö Vårdcental
City
Stockholm
State/Province
Älvsjö
ZIP/Postal Code
12531
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lena Reuterskiöld, PhD
Phone
+46702580625
Email
lena.reuterskiold@regionstockholm.se
First Name & Middle Initial & Last Name & Degree
Director
Phone
+4612367751
Email
sandra.afwinklerfelt-hammarberg@regionstockholm.se

12. IPD Sharing Statement

Learn more about this trial

Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.

We'll reach out to this number within 24 hrs